MedTrace Logo

Venticute in Patients With Pneumonia or Aspiration of Gastric Contents and Intubation/Ventilation/Oxygenation Impairment (BY2001/M1-007)

NCT00074906 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2012-05-07

No results posted yet for this study

Summary

Study to demonstrate that administration of Venticute increases survival of patients with pneumonia or aspiration of gastric contents leading to intubation, mechanical ventilation, and severe oxygenation impairment.

Conditions

Interventions

DRUG

Venticute

Patients With Pneumonia or Aspiration of Gastric Contents and Intubation/Ventilation/Oxygenation Impairment

Sponsors & Collaborators

Principal Investigators

  • Roger G. Spragg, MD · University of California and La Jolla Veterans Affairs Medical Center, San Diego, CA, USA

  • Werner Seeger, MD · Justus-Liebig-Universität, Gießen, Germany

  • Andreas Günther, MD · University of Giessen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-11-30
Primary Completion
2008-03-31
Completion
2008-06-30

Countries

  • Australia
  • Austria
  • Belgium
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Israel
  • Netherlands
  • New Zealand
  • Russia
  • South Africa
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00074906 on ClinicalTrials.gov